Dissociative sedation for pediatric procedures in emergency care
Ketamine is a phencyclidine (PCP) derivative that acts as a dissociative sedative through antagonism of the N-methyl-D-aspartate (NMDA) receptor. It has anxiolytic, analgesic, amnesic and dissociative properties with a wide safety margin.
| Phase | Time |
|---|---|
| Clinical onset | 1 minute |
| Effective sedation | 10 - 20 minutes |
| Time to discharge | 90 minutes |
Ketamine can be used for procedural sedation in children over 12 months of age who will need a painful or frightening procedure during the course of their emergency care. It can be used instead of general anaesthesia for minor and moderate procedures.
Most side effects self-resolve and require observation only.
| Side Effect | Incidence |
|---|---|
| Mild agitation | 20% |
| Moderate/severe agitation | 1.5% |
| Hypersalivation and lacrimation | <10% |
| Involuntary movements/ataxia | 5% |
| Vomiting | 5-10% |
| Transient rash | 10% |
| Airway problems | <1% |
Risk factors: Higher in children with posterior pharynx stimulation or active respiratory disease (contraindications)
Treatment: IV ondansetron 0.1mg/kg (maximum 4mg) by slow IV injection
Recent food intake should not be considered as a contraindication to ketamine use. Consider fasting state in relation to procedure urgency and comorbidities.
Supplemental oxygen should be given prior to and during the procedure. Evidence supports safety of using 'room air' only during ketamine sedation if mask use interferes with procedure.
Complete medical record and local audit documentation. Document and review all adverse events. Report clinical incidents as appropriate.